KraneShares MSCI All China Health Care Index ETF KURE

Medalist Rating as of | See Kraneshares Investment Hub

Morningstar’s Analysis KURE

Will KURE outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

KraneShares MSCI All China Hlth Care ETF holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings KURE

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 53.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Innovent Biologics Inc

9.01 8M
Healthcare

BeOne Medicines Ltd Ordinary Shares

8.75 8M
Healthcare

WuXi Biologics (Cayman) Inc

7.58 7M
Healthcare

Wuxi AppTec Co Ltd Class A

5.20 5M
Healthcare

Jiangsu Hengrui Pharmaceuticals Co Ltd Class A

4.36 4M
Healthcare

Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A

4.19 4M
Healthcare

Akeso Inc Ordinary Shares

3.94 4M
Healthcare

CSPC Pharmaceutical Group Ltd

3.69 3M
Healthcare

Sino Biopharmaceutical Ltd

3.60 3M
Healthcare

Wuxi AppTec Co Ltd

3.14 3M
Healthcare

Sponsor Center